CGC Company Profile and Key Details

Canopy Growth Corporation generated EPS of -$1.95 over the past year. Five-year average earnings growth is 32.5%. Wall Street analysts project EPS growth of 72.49% annually over the next five years. The latest quarter delivered EPS of -$0.01. The next quarter is forecast at -$0.04. Next year's EPS is expected at $62.35. Canopy Growth Corporation earnings surprise history is a mixed track record. The quarter that ended November 07, 2025, missed forecasts by -93.47%. The prior quarter beat by -6.67%. Over the last six quarters, Apple has recorded several small beats. These include 278.55% in August 09, 2024.

Short-term trend indicators are bullishly aligned (SMA20 -8.01%, SMA50 -13.25%, SMA200 -17.64%). The stock’s 14-day RSI is 40.24 (neutral), while the ATR of 0.08 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -62.76% below its high and over 40.26% above its low. Average 10-day trading volume of 13.01 million shares is below the 3-month average of 26.19 million, indicating normal recent market interest.

Canopy Growth Corporation last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $5.61. This means the shares are trading below this model’s fair value.

Canopy Growth Corporation has 311.99 million shares outstanding. The public float is 239.75 million shares, elevated short interest at 6.76% of float. This equals 21.10 million shares. The short ratio is 0.8 days. Institutional investors hold 7.27% of the float. Insiders own 0.07%. Mongeau Luc holds 812.37 thousand shares, Hong Judy Eun Joo has 579.89 thousand shares and SCHMELING JUDY has 420.54 thousand shares. Over the past six months, insider transactions show net selling. They sold 92.13 thousand shares across 9 transactions.

Canopy Growth Corporation (NASDAQ:CGC) closed at $1.12 USD, gaining $0.04 (3.70%) from the previous close of $1.08. The stock is currently mid-range between its 52-week high and low $0.77 and $2.38. With a market capitalization of about $576.26 million, Canopy Growth Corporation is classified as a small-cap and shows higher-than-market volatility (beta ~2.40). Key stats such as the average daily volume over the past year has been around 30.36 million shares, volume is running light vs its 52-week average. Headquartered in Smiths Falls, ON, Canopy Growth Corporation operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Luc Mongeau, the company employs approximately 1,029 people and listed since April 07, 2014. Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany.

Canopy Growth Corporation trades at a P/E ratio of -1.08, slightly below the S&P 500 average, with a price-to-sales ratio of 2.8 and a price-to-book ratio of 0.56 suggesting the stock is closer to book value. The P/FCF stands at -8.11, also below market averages.

Canopy Growth Corporation (NASDAQ:CGC) shares are flat 0.88% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Canopy Growth Corporation trading at a premium to the broader market with a P/E of -1.08. Analyst sentiment is cautious, with the majority of ratings in Underweight territory and a mean price target of $8.86, suggesting 705.45% upside. Our AI forecast model points to short-term weakness (-2.73% over two weeks), a medium-term fall (-42.73% over three months), and a longer-term gain (44.55% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Canopy Growth Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -2.73%, with price expected at $1.07 by February 19, 2026, within a range of $0.95 to $1.18 3-Month Outlook: Projected fall of -42.73%, reaching $0.63 by May 06, 2026, with a range of $0.52 to $0.74. 1-Year Outlook: Projected gain of 44.55%, with price at $1.59 by February 05, 2027, within a range of $0.00 to $0.00.